Cancernetwork.com / Trials



Domain overview in Trials niche. Based on relevant links and pages only.
cancernetwork.com rank
405
Number of domains linking to cancernetwork.com
13
semantic flow
1.15
Number of links to cancernetwork.com
26
semantic flow
1.15
Number of domains linked from cancernetwork.com
3
semantic flow
0.26
Number of links from cancernetwork.com
5
semantic flow
0.26

Popular pages pointing to cancernetwork.com

Pages with highest topical PageRank pointing to domain.

url / atext / target url
https://ocrfa.org/2017/04/cediranib-effect-quality-life/
cancer network
http://www.cancernetwork.com/gynecologic-cancers/cediranib-does-not-reduce-qol-relapsed-ov
ocrfa.org
https://www.cooperhealth.org/services/cancer-and-pregnancy
view the video
http://www.cancernetwork.com/mbcc-2015/exposure-utero-chemotherapy-did-not-affect-children
www.cooperhealth.org
http://www.cancernetwork.com/gynecologic-cancers/cediranib-does-not-reduce-qol-relapsed-ov
gynecologic cancers
http://www.cancernetwork.com/gynecologic-cancers
http://www.cancernetwork.com/gynecologic-cancers/cediranib-does-not-reduce-qol-relapsed-ov
fda grants priority review for rucaparib as ovarian cancer maintenance therapy
http://www.cancernetwork.com/article/fda-grants-priority-review-rucaparib-ovarian-cancer-m
http://www.cancernetwork.com/gynecologic-cancers/cediranib-does-not-reduce-qol-relapsed-ov
ovarian cancer
http://www.cancernetwork.com/ovarian-cancer
http://www.cancernetwork.com/gynecologic-cancers/cediranib-does-not-reduce-qol-relapsed-ov
pazopanib added to paclitaxel does not improve ovarian cancer outcomes
http://www.cancernetwork.com/article/pazopanib-added-paclitaxel-does-not-improve-ovarian-c
http://www.cancernetwork.com/gynecologic-cancers/cediranib-does-not-reduce-qol-relapsed-ov
survival benefit not enough to justify centralized ovarian cancer care
http://www.cancernetwork.com/article/survival-benefit-not-enough-justify-centralized-ovari
http://www.cancernetwork.com/gynecologic-cancers/cediranib-does-not-reduce-qol-relapsed-ov
extending platinum free interval in ovarian cancer does not improve outcomes
http://www.cancernetwork.com/article/extending-platinum-free-interval-ovarian-cancer-does-
http://www.cancernetwork.com/gynecologic-cancers/cediranib-does-not-reduce-qol-relapsed-ov
partner content
http://www.cancernetwork.com/news/cediranib-does-not-reduce-qol-relapsed-ovarian-cancer-th

Popular pages from cancernetwork.com

On-topic pages from domain with highest topical PageRank.

title / url
PR


info
relevance


info
links


info
rel links


info
external links


info
external domains


info
referring domains


info
external backlinks


info
Cediranib Does Not Reduce QOL in Relapsed Ovarian Cancer Therapy | Cancer Network | The Oncology Journal
http://www.cancernetwork.com/gynecologic-cancers/cediranib-does-not-reduce-qol-relapsed-ov
0.210.9634174211

Domains with most semantic flow to cancernetwork.com

Relevant domains with most links to selected domain.

domain info
count


info
semantic flow


info
http://lungevity.org/ 100.51lungevity.org
http://breastcancertrials.org/ 30.14breastcancertrials.org
http://massgeneral.org/ 30.1massgeneral.org
http://ocrfa.org/ 10.08ocrfa.org
http://gastriccancer.org/ 10.07gastriccancer.org
http://tahoecancercenter.com/ 10.07tahoecancercenter.com
http://exelixis.com/ 10.07exelixis.com
http://drsusanloveresearch.org/ 10.04drsusanloveresearch.org
http://cancerindex.org/ 10.03cancerindex.org
http://cooperhealth.org/ 10.02cooperhealth.org

Domains with most semantic flow from cancernetwork.com

Relevant domains with most links from selected domain.

domain info
count


info
semantic flow


info
http://ubmmedica.com/ 30.16ubmmedica.com
http://ascopubs.org/ 10.06ascopubs.org
http://jamanetwork.com/ 10.04jamanetwork.com

Hubs from cancernetwork.com

Pages from domain with most likely on-topic outgoing links.

url
count


info
PR


info
score


info
semantic flow


info
relevance


info
on topic


info
links


info
rel links


info
external links


info
external domains


info
referring domains


info
external backlinks


info
http://www.cancernetwork.com/palliative-and-supportive-care/early-palliative-care-improves 150.150.940.80.89yes34154211
http://www.cancernetwork.com/breast-cancer 90.160.920.460.85yes41183100
http://www.cancernetwork.com/gastrointestinal-cancer 90.160.930.440.83yes44183100
http://www.cancernetwork.com/head-neck-cancer 90.160.930.18-1no-1-1-1-100
http://www.cancernetwork.com/lung-cancer 80.160.930.310.73yes42173100
http://www.cancernetwork.com/palliative-and-supportive-care 80.160.880.20.57yes49173100
http://www.cancernetwork.com/gynecologic-cancers/cediranib-does-not-reduce-qol-relapsed-ov 70.210.930.60.96yes34174211
http://www.cancernetwork.com/article/fda-approves-second-biosimilar-cancer 60.160.890.320.87yes34163100
http://www.cancernetwork.com/bladder-cancer 60.160.930.260.81yes43153100
http://www.cancernetwork.com/article/deciding-duration-adjuvant-chemotherapy-patient-stage 50.160.880.330.99yes34153100

contact | terms | privacy
© 2018-2024 semanticjuice.com